Literature DB >> 16415390

Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.

Catherine E Browning1, Jeffrey P Callen.   

Abstract

BACKGROUND: Livedoid vasculopathy is an idiopathic, chronic disorder manifested by painful, purpuric macules on the lower extremities that superficially ulcerate, resulting in atrophic, stellate scars with peripheral telangiectasias and hyperpigmentation. OBSERVATIONS: A 50-year-old man presented with recurrent, painful ulcerations on the medial aspect of his malleoli and calves. The clinical presentation, histologic findings, and results of laboratory evaluation confirmed the diagnosis of livedoid vasculopathy in this case. Despite being refractory to treatment with multiple other medications, the lesions responded dramatically to oral warfarin sodium therapy.
CONCLUSION: Treatment with warfarin may be a beneficial therapy for patients with livedoid vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415390     DOI: 10.1001/archderm.142.1.75

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  12 in total

1.  Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.

Authors:  Mehmet Agirbasli; Mesut Eren; Fatih Eren; Sheila B Murphy; Zehra A Serdar; Dilek Seckin; Tuba Zara; M Cem Mat; Cuyan Demirkesen; Douglas E Vaughan
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

2.  Livedoid thrombotic vasculopathy responding to doxycycline therapy.

Authors:  Matthew S Keller; Jason Lee; Guy F Webster
Journal:  J Clin Aesthet Dermatol       Date:  2008-11

Review 3.  [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].

Authors:  T Goerge
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

4.  Cryofibrinogenaemia: not just skin deep.

Authors:  Zahrae Sandouk; Zaid Alirhayim; Syed Hassan; Waqas Qureshi
Journal:  BMJ Case Rep       Date:  2013-02-20

5.  Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.

Authors:  Noha A Irani-Hakime; Farid Stephan; Raghid Kreidy; Isabelle Jureidini; Wassim Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2008-03-23       Impact factor: 2.300

6.  Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases.

Authors:  Mariana Quirino Tubone; Gabriela Fortes Escobar; Juliano Peruzzo; Pedro Schestatsky; Gabriela Maldonado
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

7.  A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.

Authors:  Attyla Drabik; Carina Hillgruber; Tobias Goerge
Journal:  JMIR Res Protoc       Date:  2014-12-10

8.  Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy.

Authors:  Wenji Chen; Lina Fan; Yanyan Wang; Xiaohu Deng
Journal:  J Pain Res       Date:  2017-03-17       Impact factor: 3.133

9.  Reticulate dermatoses.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

10.  Use of Low-dose Oral Warfarin in Three Cases of Livedoid Vasculopathy.

Authors:  Vikrant Saoji; Bhushan Madke
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.